Quantifying mortality burden in patients with cancer due to COVID-19 in the US: A national cross-sectional analysis.
cancer risk factors
epidemiology and prevention
medical oncology
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
06
07
2023
received:
11
04
2023
accepted:
09
07
2023
medline:
15
9
2023
pubmed:
4
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
There is limited information on the impact of certain social factors on mortality outcomes in patients with cancer and COVID-19 on a national scale. This study aims to characterize excess mortality and analyze a subset of sociodemographic trends in COVID-19 and cancer mortality. Patients with cancer listed on their death certificates from 2018 to 2021 and patients with COVID-19 and cancer listed on multiple cause of death certificates from the CDC Wide-Ranging Online Data for Epidemiologic Research database from March 2020 to December 2021 were included. Age-adjusted mortality rates (AAMR) per 1,000,000 population were compared across race/ethnicity groups, sex, and census regions. Crude mortality rates were compared across different age groups and regions based on urbanization status. Average AAMR in patients with COVID-19 and cancer was 41.7 in 2020 and 56.7 in 2021. Mortality rates in patients with cancer and COVID-19 were significantly higher in certain populations. Targeted interventions are necessary to improve outcomes.
Identifiants
pubmed: 37537960
doi: 10.1002/cam4.6364
pmc: PMC10501232
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17413-17417Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Int J Environ Res Public Health. 2022 Sep 30;19(19):
pubmed: 36231769
Vital Health Stat 2. 2014 Apr;(166):1-73
pubmed: 24776070
Curr Oncol Rep. 2022 Oct;24(10):1219-1235
pubmed: 35622263
Trans R Soc Trop Med Hyg. 2022 Sep 10;116(9):767-797
pubmed: 35276734
J Gen Intern Med. 2023 Apr;38(5):1344-1347
pubmed: 36750506
J Cancer Biol. 2021;2(1):25-32
pubmed: 34447972
JAMA Oncol. 2022 Jan 1;8(1):69-78
pubmed: 34709356
Cancer Rep (Hoboken). 2021 Oct;4(5):e1388
pubmed: 34014037
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
JAMA Oncol. 2022 Nov 1;8(11):1696-1698
pubmed: 36173612
Cancer Med. 2023 Aug;12(16):17413-17417
pubmed: 37537960